SEC Form D private-offering filing

Starget Pharma Inc.

Name: Starget Pharma Inc. - new SEC Form D private-offering filing, Shreveport, LA
Published: 2026-02-03

A new SEC Form D private-offering notice from Shreveport, LA, a $22,158,515 filer-stated offering target in Biotech. The source filing is one click away.

Starget Pharma Inc. site↗ Verified via SEC Form D

Clinical stage radiopharmaceutical company developing peptide based radioligand therapies for cancer, with a lead program targeting somatostatin receptor 3 (SSTR3) tumors.

Filed 2026-02-03Filed to raise $22,158,515First money in 2026-01-20Raised so far $16,373,737HQ (as filed) Shreveport, LASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified stargetpharma.com↗Named in the filing 2 executives & directors

Open this row on the live feed →More new filings in Louisiana →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.